← Leaderboards
Sungjin Ko
University Of Pittsburgh At Pittsburgh
$2,106,701
Attributed
$2,106,701
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $841.7K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,106,701 · 2
By mechanism
R01$2,106,701 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Wen Xie$22,052,503
- Kari N Nejak-Bowen$7,645,432
- Joseph C. Glorioso$19,383,290
- Da Yang$5,984,718
- Jaideep Behari$4,660,334
Others in their field
Other Emerging Leaders on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- James Dale Berry · Brigham And Women'S Hospital$25,538,716
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
- Gary Fanger · Rise Therapeutics, Llc$17,847,765
Research focus
MediatingOperative Surgical ProceduresInjuryLiverMolecular ProfilingNewly DiagnosedGenetic TranscriptionHepatocyteInnovationIn VivoMolecularAutomobile DrivingBiological MarkersNeoplastic CellGenesGeneticCellsClinicData SetExcisionChip-SeqCholangiocarcinomaBioinformaticsPathologic
Grant awards (6)
Deciphering the Molecular Mechanisms Underlying Cholangiocarcinoma Development$518,219
R01 · FY2025 · CA · contact PI
Identifying therapeutic options for intrahepatic cholangiocarcinoma$323,497
R01 · FY2025 · CA · contact PI
Identifying therapeutic options for intrahepatic cholangiocarcinoma$307,323
R01 · FY2024 · CA · contact PI
Identifying therapeutic options for intrahepatic cholangiocarcinoma$317,027
R01 · FY2023 · CA · contact PI
Identifying therapeutic options for intrahepatic cholangiocarcinoma$322,225
R01 · FY2022 · CA · contact PI
Identifying therapeutic options for intrahepatic cholangiocarcinoma$318,410
R01 · FY2021 · CA · contact PI